Europe approves antibodies from AstraZeneca and Sanofi to prevent RSV…
The European Commission has approved AstraZeneca plc AZN and Sanofi SA SNY Beyfortus (nirsevimab), long-acting antibody to prevent lower respiratory tract respiratory syncytial virus (RSV)